Item

Alpha Lipoic Acid (ALIPA)

We hereby confirm that this material is 100% Alpha Lipoic Acid.
Attributes
  • Gluten-free
  • Ingredient declaration
Locations
Location name Address
Fuller Enterprise USA Inc. 1735 E. Grevillea Ct. Ontario, CA 91761
Jiangsu Tohope Pharmaceutical Co., Ltd. 188 Wuyishan road Southeast Economoc Development Zone Changshu City, JS 21553 CHN
Shandong Luning Pharmaceutical Co., Ltd North of Qigong Road, East of Yongan Road, Daozhuang Town, Guangrao County Dongying, SD 257336 CHN
Suzhou Fushilai Pharmaceutical Co Ltd. No 16, Haiwang Rd., Changsu Advanced Material Industrial Park Changshu, Jiangsu Province 215500 CHN
Documents
Type Location File name Effective Expiration
Allergens Suzhou Fushilai Pharmaceutical Co Ltd. Allergens.pdf 9/7/2022 9/6/2024
Animal Testing Statement Jiangsu Tohope Pharmaceutical Co., Ltd. Animal Testing Statement.pdf 10/26/2021 10/26/2023
BSE - TSE Suzhou Fushilai Pharmaceutical Co Ltd. BSE.TSE Free Statement.pdf 5/15/2021 5/14/2024
BSE - TSE Shandong Luning Pharmaceutical Co., Ltd BSE.TSE Statement.pdf 7/22/2022 7/21/2025
BSE - TSE Fuller Enterprise USA Inc. BSETSE Free Statement.pdf 6/11/2021 6/10/2024
Ingredient Statement Jiangsu Tohope Pharmaceutical Co., Ltd. Composition Statement.pdf 6/11/2021 6/11/2022
Ingredient Statement Shandong Luning Pharmaceutical Co., Ltd Composition Statement.pdf 5/28/2021 5/28/2022
Country of Origin Jiangsu Tohope Pharmaceutical Co., Ltd. Country of Origin.pdf 6/14/2022 6/13/2025
Country of Origin Shandong Luning Pharmaceutical Co., Ltd Country of Origin.pdf 9/7/2022 9/6/2025
Dietary Supplement Questionnaire Jiangsu Tohope Pharmaceutical Co., Ltd. Dietary Supplement Questionnaire.pdf 6/14/2022 6/14/2023
HACCP Process Flow Diagram Shandong Luning Pharmaceutical Co., Ltd Flow Chart.PDF 12/1/2021 12/1/2023
HACCP Process Flow Diagram Suzhou Fushilai Pharmaceutical Co Ltd. Flow Chart.pdf 9/7/2022 9/6/2024
Gluten Suzhou Fushilai Pharmaceutical Co Ltd. Gluten Free Statement.pdf 1/3/2020 1/2/2021
Halal Shandong Luning Pharmaceutical Co., Ltd Halal Statement.pdf 9/7/2022 9/7/2025
Item Questionnaire Suzhou Fushilai Pharmaceutical Co Ltd. Item Questionnaire.pdf 10/20/2022 10/19/2025
Kosher Suzhou Fushilai Pharmaceutical Co Ltd. Kosher - 2023.04.30.pdf 5/6/2022 4/30/2023
Kosher Shandong Luning Pharmaceutical Co., Ltd Kosher Declaration.jpg 4/30/2021 4/30/2024
Lot Code Jiangsu Tohope Pharmaceutical Co., Ltd. Lot Code Definition Statement.pdf 10/26/2021 10/25/2024
Melamine Fuller Enterprise USA Inc. Melamine Free Statement.pdf 6/19/2020 6/19/2021
Melamine Jiangsu Tohope Pharmaceutical Co., Ltd. Melamine Free Statement.pdf 3/15/2021 3/15/2022
Safety Data Sheet (SDS) Shandong Luning Pharmaceutical Co., Ltd MSDS.pdf 9/7/2022 9/6/2025
Safety Data Sheet (SDS) Suzhou Fushilai Pharmaceutical Co Ltd. MSDS.pdf 7/1/2021 6/30/2024
No Animal Ingredient Statement Jiangsu Tohope Pharmaceutical Co., Ltd. No Animal Ingredient Statement.pdf 10/26/2021 10/26/2022
EtO Statement Shandong Luning Pharmaceutical Co., Ltd Non-ETO Statement.pdf 7/22/2022 7/21/2024
EtO Statement Suzhou Fushilai Pharmaceutical Co Ltd. Non-ETO Statement.pdf 9/26/2021 9/26/2023
Irradiation Status Statement Fuller Enterprise USA Inc. Non-ETOIrradiation Statement.pdf 6/11/2021 6/11/2023
GMO Shandong Luning Pharmaceutical Co., Ltd Non-GMO Statement.pdf 9/7/2022 9/6/2024
GMO Suzhou Fushilai Pharmaceutical Co Ltd. Non-GMO Statement.pdf 1/25/2021 1/25/2023
Sewage Statement Suzhou Fushilai Pharmaceutical Co Ltd. Non-Irradiation.Sewage Sludge Statement.pdf 7/9/2019 7/8/2021
Irradiation Status Statement Suzhou Fushilai Pharmaceutical Co Ltd. Non-Irradiation.Sewage Sludge Statement.pdf 7/9/2019 7/8/2021
Halal Fuller Enterprise USA Inc. NotApplicable_Halal.pdf 1/20/2023 1/20/2024
Kosher Fuller Enterprise USA Inc. NotApplicable_Kosher.pdf 1/20/2023 1/20/2024
Natural Fuller Enterprise USA Inc. NotApplicable_Natural.pdf 12/10/2022 12/10/2023
No Animal Ingredient Statement Fuller Enterprise USA Inc. NotApplicable_NoAnimalIngredientStatement.pdf 12/10/2022 12/10/2023
Nutrition Fuller Enterprise USA Inc. NotApplicable_Nutrition.pdf 12/10/2022 12/9/2025
Organic Fuller Enterprise USA Inc. NotApplicable_Organic.pdf 9/19/2022 9/19/2023
Pesticide Fuller Enterprise USA Inc. NotApplicable_Pesticide.pdf 12/10/2022 12/9/2024
Phthalate Esters Letter Fuller Enterprise USA Inc. NotApplicable_PhthalateEstersLetter.pdf 12/10/2022 12/10/2023
Product Specification Sheet Fuller Enterprise USA Inc. NotApplicable_ProductSpecificationSheet.pdf 12/10/2022 12/9/2025
Residual Statement Fuller Enterprise USA Inc. NotApplicable_ResidualStatement.pdf 12/10/2022 12/10/2023
Sewage Statement Fuller Enterprise USA Inc. NotApplicable_SewageStatement.pdf 12/10/2022 12/9/2024
Shelf Life Fuller Enterprise USA Inc. NotApplicable_ShelfLife.pdf 12/10/2022 12/9/2024
Suitability Requirements Fuller Enterprise USA Inc. NotApplicable_SuitabilityRequirements.pdf 12/10/2022 12/9/2025
Nutrition Jiangsu Tohope Pharmaceutical Co., Ltd. Nutrition.pdf 1/19/2022 1/18/2025
Pesticide Suzhou Fushilai Pharmaceutical Co Ltd. Pesticide Free Statement.pdf 12/9/2020 12/9/2022
California Prop. 65 Jiangsu Tohope Pharmaceutical Co., Ltd. Prop 65 Statement.pdf 7/4/2021 7/4/2023
California Prop. 65 Suzhou Fushilai Pharmaceutical Co Ltd. Prop 65 Statement.pdf 7/8/2019 7/7/2021
Label Sample Jiangsu Tohope Pharmaceutical Co., Ltd. Sample of Label.jpg 9/17/2021 9/17/2022
Safety Data Sheet (SDS) Fuller Enterprise USA Inc. SDS.pdf 7/10/2019 7/9/2021
Safety Data Sheet (SDS) Jiangsu Tohope Pharmaceutical Co., Ltd. SDS.pdf 7/10/2019 7/9/2022
Product Specification Sheet Shandong Luning Pharmaceutical Co., Ltd Specification Sheet.pdf 9/7/2022 9/6/2025
Vegan/Vegetarian Statement Fuller Enterprise USA Inc. Vegan Statement.pdf 6/11/2021 6/11/2023
Vegan/Vegetarian Statement Shandong Luning Pharmaceutical Co., Ltd Vegan Statement.pdf 9/7/2022 9/6/2024
Vegan/Vegetarian Statement Suzhou Fushilai Pharmaceutical Co Ltd. Vegan Statement.pdf 7/8/2021 7/8/2023
WADA/NSF/NFL Statement Fuller Enterprise USA Inc. WADA Statement.pdf 6/11/2021 6/11/2023
WADA/NSF/NFL Statement Suzhou Fushilai Pharmaceutical Co Ltd. WADA Statement.pdf 7/8/2021 7/8/2023